Get all company financials in excel:

Download Sample   $19.99

More Charts

Walmark is a Czech Republic-based producer of food supplements. The Company has been created at the beginning of 1990's as a greenfield investment. Nowadays, Walmark maintains its strong position in the Czech Republic, set up subsidiaries in seven other CEE markets and exports to further 30 countries in the world. Walmark's portfolio includes products such as Martians (multivitamins and multiminerals for childern), Spektrum (multivitamins and multiminerals for adults of all ages), ArthroStop (preparations for joint nutrition), GinkoPrim (herbal extract for better blood circulation), Prostenal, Urinal, or Dialevel, for example. In 2012, the Company achieved total sales of over CZK 2.1 bil and employed nearly 900 people

Finance

Walmark has been growing its sales by a year on average in the last 5 years. EBITDA has fallen on average by 0.377% a year during that time to total of CZK 146 mil in 2017, or 10.1% of sales. That’s compared to 0.755% average margin seen in last five years.

The company netted CZK 124 mil in 2017 implying ROE of -67.9% and ROCE of 10.9%. Again, the average figures were -41.4% and -11.2%, respectively when looking at the previous 5 years.

Walmark’s net debt amounted to CZK 1,089 mil at the end of 2017, or -773% of equity. When compared to EBITDA, net debt was 7.44x, up when compared to average of -5.35x seen in the last 5 years.